Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Chordae Tendineae Rupture in the United States: Trends of Outcomes, Costs and Surgical Interventions.

Dolmatova EV, Moazzami K, Maher J, Klapholz M, Sambol J, Waller AH.

Heart Surg Forum. 2017 Feb 27;20(1):E019-E025. doi: 10.1532/hsf.1625.

PMID:
28263146
2.

In-Hospital Outcomes and Complications of Coronary Artery Bypass Grafting in the United States Between 2008 and 2012.

Moazzami K, Dolmatova E, Maher J, Gerula C, Sambol J, Klapholz M, Waller AH.

J Cardiothorac Vasc Anesth. 2017 Feb;31(1):19-25. doi: 10.1053/j.jvca.2016.08.008. Epub 2016 Aug 10.

PMID:
27887898
3.

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Quyyumi AA, Vasquez A, Kereiakes DJ, Klapholz M, Schaer GL, Abdel-Latif A, Frohwein S, Henry TD, Schatz RA, Dib N, Toma C, Davidson CJ, Barsness GW, Shavelle DM, Cohen M, Poole J, Moss T, Hyde P, Kanakaraj AM, Druker V, Chung A, Junge C, Preti RA, Smith RL, Mazzo DJ, Pecora A, Losordo DW.

Circ Res. 2017 Jan 20;120(2):324-331. doi: 10.1161/CIRCRESAHA.115.308165. Epub 2016 Nov 7.

PMID:
27821724
4.

Impact of Hospital Teaching Status on Mortality, Length of Stay and Cost Among Patients With Cardiac Arrest in the United States.

Dolmatova EV, Moazzami K, Klapholz M, Kothari N, Feurdean M, Waller AH.

Am J Cardiol. 2016 Sep 1;118(5):668-72. doi: 10.1016/j.amjcard.2016.05.062. Epub 2016 Jun 15.

PMID:
27378144
5.

QT Prolongation and Clinical Outcomes in Patients with Takotsubo Cardiomyopathy.

Imran TF, Rahman I, Dikdan S, Shah R, Niazi OT, Thirunahari N, Alhaj E, Klapholz M, Gaziano JM, Djousse L.

Pacing Clin Electrophysiol. 2016 Jun;39(6):607-11. doi: 10.1111/pace.12864. Epub 2016 May 4.

PMID:
27062153
6.

Unicuspid unicommissural aortic valve: an extremely rare congenital anomaly.

Singh S, Ghayal P, Mathur A, Mysliwiec M, Lovoulos C, Solanki P, Klapholz M, Maher J.

Tex Heart Inst J. 2015 Jun 1;42(3):273-6. doi: 10.14503/THIJ-13-3634. eCollection 2015 Jun.

7.

Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF).

Maurer MS, Adamson PB, Costanzo MR, Eigler N, Gilbert J, Gold MR, Klapholz M, Saxon LA, Singh JP, Troughton R, Abraham WT.

J Card Fail. 2015 Jun;21(6):479-88. doi: 10.1016/j.cardfail.2015.04.012. Epub 2015 Apr 25.

PMID:
25921522
8.

Risperidone unmasking an accessory pathway.

Imran TF, Niazi OT, Amin R, Mazza V, Klapholz M.

Int J Cardiol. 2015;187:488-90. doi: 10.1016/j.ijcard.2015.03.419. Epub 2015 Mar 31. No abstract available.

PMID:
25863733
9.

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators..

Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7.

10.

Hypertension in African Americans with heart failure: progression from hypertrophy to dilatation; perhaps not.

Solanki P, Zakir RM, Patel RJ, Pentakota SR, Maher J, Gerula C, Saric M, Kaluski E, Klapholz M.

High Blood Press Cardiovasc Prev. 2015 Mar;22(1):61-8. doi: 10.1007/s40292-014-0070-3. Epub 2014 Nov 20.

PMID:
25411129
11.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators..

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.

12.

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Pullicino PM, Qian M, Sacco RL, Freudenberger R, Graham S, Teerlink JR, Mann D, Di Tullio MR, Ponikowski P, Lok DJ, Anker SD, Lip GY, Estol CJ, Levin B, Mohr JP, Thompson JL, Homma S; WARCEF Investigators..

Cerebrovasc Dis. 2014;38(3):176-81. doi: 10.1159/000365502. Epub 2014 Oct 9.

13.

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees..

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.

14.

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators..

JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.

PMID:
24682069
15.

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T; REVIVE Heart Failure Study Group..

JACC Heart Fail. 2013 Apr;1(2):103-11. doi: 10.1016/j.jchf.2012.12.004. Epub 2013 Apr 1.

PMID:
24621834
16.

The effects of exercise on dynamic sleep morphology in healthy controls and patients with chronic fatigue syndrome.

Kishi A, Togo F, Cook DB, Klapholz M, Yamamoto Y, Rapoport DM, Natelson BH.

Physiol Rep. 2013 Nov;1(6):e00152. doi: 10.1002/phy2.152. Epub 2013 Nov 13.

17.

Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndrome.

Nakamura T, Schwander S, Donnelly R, Cook DB, Ortega F, Togo F, Yamamoto Y, Cherniack NS, Klapholz M, Rapoport D, Natelson BH.

Clin Vaccine Immunol. 2013 Nov;20(11):1736-42. doi: 10.1128/CVI.00527-13. Epub 2013 Sep 11.

18.

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators..

Eur Heart J. 2013 Oct;34(40):3117-27. doi: 10.1093/eurheartj/eht342. Epub 2013 Sep 2.

19.

Atypical stress-induced cardiomyopathy: a case series.

Alhaj E, Ahmad US, Niazi OT, Zakhary D, Akhtar M, Zabolotsky A, Oriscello R, Voudouris A, Kaluski E, Klapholz M.

Acta Cardiol. 2013 Apr;68(2):222-5.

20.

Fibromuscular dysplasia of the renal artery: an underdiagnosed cause of severe hypertension.

Alhaj EK, Alhaj NK, Klapholz M.

Int J Cardiol. 2013 Sep 10;167(6):e159-60. doi: 10.1016/j.ijcard.2013.04.189. Epub 2013 May 17. No abstract available.

PMID:
23684605

Supplemental Content

Loading ...
Support Center